Blog - Page 1153 of 5707

WednesdayNov 10, 2021 2:31 pm

QualityStocksNewsBreaks – Avricore Health Inc. (TSX.V: AVCR) (OTCQB: AVCRF) Eyeing Opportunities in the US, UK and EU, Generating Interest Among Latin American and Caribbean Countries

Avricore Health (TSX.V: AVCR) (OTCQB: AVCRF) was featured in a recent “Bell2Bell” podcast episode in which CEO Hector Bremner discussed the company’s history, its goals and the plans it has for development further down the road. “Avricore’s flagship HealthTab(TM) platform partners currently with Abbott Rapid Diagnostics’ Afinion 2(TM) and ID Now(TM) analyzers, as well as Abaxis Global Diagnostics’ Piccolo Xpress to conduct blood or molecular testing at a neighborhood pharmacy and then shares the data from tests not only with the patient but also with medical professionals and researchers without compromising health privacy,” reads a recent article. Avricore accomplished the…

WednesdayNov 10, 2021 2:07 pm

QualityStocksNewsBreaks – Friendable Inc. (FDBL) Supporting and Promoting Artists at Every Stage

Friendable (OTC: FDBL), a mobile technology and marketing company, recently announced a unique opportunity for artists on the Fan Pass live streaming platform. Titled “Double Down” October, the contest gave artists on the platform the opportunity to double the revenue they earned for the entire month. For every dollar that an artist made, Friendable matched it on all ticket and merchandise sales. The top three revenue-earning artists for the month also received additional monetary prizes. “Robert A. Rositano Jr., CEO and co-founder of Friendable, said Fan Pass continues to look for ways to promote its artist members while also providing…

WednesdayNov 10, 2021 2:01 pm

DigiMax Global Inc.’s (CSE: DIGI) (OTC: DBKSF) AI-Powered Hedge Fund Gives Investors Exposure to Crypto

Hedge funds with artificial intelligence capabilities showed competitive edge over investors that didn’t use AI Top reason given for using algorithms is to reduce market impact The fund offers investment opportunity capitalizing on crypto volatility and powered by proprietary trading algorithms Artificial intelligence (“AI”) is entering the world of finance — with impressive results. According to a recent “Institutional Investor” article, hedge funds that use AI returned almost triple the global industry average (https://ibn.fm/XoDrA). With that as a backdrop, DigiMax Global’s (CSE: DIGI) (OTC: DBKSF) just-launched Cryptocurrency Hedge Fund could not have come at a better time. “Hedge funds with artificial…

WednesdayNov 10, 2021 1:31 pm

DGE’s 5th Virtual Clinical Trials To Discuss Decentralized Clinical Trials And The Future of Clinical Research

Date: December 15-16 2021 Online Livestream On December 15-16, 2021, pharma companies, medical vendors, and clinicians are invited to attend the 5th Virtual Clinical Trials conference, the industry’s most trusted and long-lasting conference on clinical trials. The event is hosted by Dynamic Global Events (“DGE”), a Life Science Leader in organizing B2B Events. As clinical trials are switching to more decentralized and hybrid models, a collaborative platform for the exchange of information is vital to keep up with the rapid growth. At the 5th Virtual Clinical Trials Conference, hear from those on the front lines of these remote applications and discuss the…

WednesdayNov 10, 2021 1:23 pm

QualityStocksNewsBreaks – LQwD Fintech Corp. (TSX.V: LQWD) (OTC: LQWDF) Announces Entry into Strategic Agreement, Increase of Bitcoin Holdings

LQwD Fintech (TSX.V: LQWD) (OTC: LQWDF), a Bitcoin Lightning Network focused company developing institution-grade payment infrastructure and solutions, today announced its entry into an agreement with Israeli-based Breez Development Ltd., a leading Lightning Network service provider. As part of the agreement, LQwD intends to offer Lightning Network liquidity services to Breez clients and provide on-demand Lightning Network channels whenever required. In addition, LQwD will run one or more Breez-modified Lightning Network routing nodes and, upon completion of services, Breez will add LQwD as a liquidity partner. “We are excited to work with Breez and become a liquidity partner within the…

WednesdayNov 10, 2021 1:09 pm

QualityStocksNewsBreaks – Playgon Games Inc. (TSX.V: DEAL) (OTCQB: PLGNF) (FRA:7CR) to Upsize Previously Announced Financing to Further Support Growth Initiatives

Playgon Games (TSX.V: DEAL) (OTCQB: PLGNF) (FRA:7CR), a propriety software-as-a-service (“SaaS”) technology company delivering mobile live dealer technology to online gaming operators globally, has announced that, as a result of strong and continued investor demand and further to the company's news releases dated Oct. 28 and Nov. 3, 2021, it intends to further upsize its previously announced non-brokered private placement (the “proposed offering”) of units of the company. According to the update, the upsized proposed offering is expected to be for gross proceeds of up to $10,500,000 through the sale of up to 35,000,000 units, each at a price of…

WednesdayNov 10, 2021 12:44 pm

QualityStocksNewsBreaks – Mydecine Innovations Group (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA) CMO to Participate in Horizons’ Veterans & Families Forum

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF) (FSE: 0NFA), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, has announced that chief medical officer Dr. Rakesh Jetly will be part of the Horizons' Veterans & Families Forum. The forum is scheduled for Nov. 10, and Jetly will be a panel member for a presentation titled “The State of Care and the Case for Psychedelic Therapy.” The panel will begin at 7:30 p.m. The event is designed specifically for veterans and will be held in NYC at the Judson Memorial Church; a virtual webcast will…

WednesdayNov 10, 2021 11:51 am

InMed Pharmaceuticals Inc. (NASDAQ: INM) Files International Patent Application for Treating Neurodegenerative Diseases Using a New Rare Cannabinoid

InMed Pharmaceuticals has filed an international patent application that specifies a rare cannabinoid that may inhibit or slow the progression of neurodegenerative disease and potentially enhance the neuronal function With neurogenerative diseases affecting millions worldwide and the cost of treating patients expected to rise in the future, finding treatments and cures is a matter of increasing urgency InMed’s patent application is a promising start, expanding the company’s patent portfolio, which currently includes twelve patent families InMed Pharmaceuticals (NASDAQ: INM), a global leader in the manufacturing and pharmaceutical development of rare cannabinoids, recently filed a Patent Cooperation Treaty (“PCT”) application, titled…

WednesdayNov 10, 2021 11:25 am

QualityStocksNewsBreaks – InMed Pharmaceuticals Inc. (NASDAQ: INM) Releases Financial Results, Business Updates for Q1 2022

InMed Pharmaceuticals (NASDAQ: INM), a leader in the development, manufacturing and commercialization of rare cannabinoids, has reported its financial numbers and corporate update for first-quarter 2022, the period ended Sept. 30, 2021. Highlights of the report included the company’s completion of the BayMedica acquisition, positioning InMed as an industry leader in the manufacturing and commercialization of rare cannabinoids. In addition, InMed is focused on the process optimization of IntegraSyn(TM) as a solution for large-scale, pharmaceutical-grade Good Manufacturing Practice (“GMP") rare cannabinoid production. The company is also continuing the preclinical studies of its exclusive glaucoma program, INM-088, in preparation for human…

WednesdayNov 10, 2021 11:20 am

Sugarmade Inc. (SGMD) Looks to Leverage Expertise as It Eyes Projected Double-Digit CAGR Growth

Global cannabis market estimated to reach $19.89 billion in 2021, projected to grow at a CAGR of 27% North America projected to record the highest market share during the forecast period SGMD is expanding role as a central player in growing California cannabis delivery marketplace, developing in-house cannabis production capacity As growing numbers of consumers around the world become more aware of the potential benefits of cannabis, the market is projected to see significant growth. A new report notes that the global cannabis market is estimated to grow at a CAGR of 27.0% from 2021 to 2030 (https://ibn.fm/c3OpZ). That anticipated…

Site Search

Company Search